Enveda weight loss maintenance pill mimics exercise in early tests
If you could design an oral treatment that limits appetite and mimics some effects of physical activity, you…
Former OpenAI exec Fidji Simo’s health care company has analyzed 3,500 vials of blood with AI
When Fidji Simo announced she was leaving her role as one of the most senior members of OpenAI’s…
6-year-old girl dies after parents paid $860K for experimental therapy
In an effort to treat their daughter’s genetic developmental disorder, parents in China paid respected researchers millions in…
Novato dementia drug startup gets venture capital infusion
A Novato startup company that is researching the connection between Alzheimer’s disease and a bacteria found in gum…
Investment in Israeli health tech startups dove 40% in 2025 – report
Investment in local healthcare-focused startups last year plunged to their lowest level in five years, after a slight…
A Cambridge PhD discovery raised £1.5M led by SCVC to fix gene therapy’s costly flaw — TFN
Houdini Bio has secured around £1.5 million in grants and pre-seed funding, with SCVC leading the investment. The…
This young startup is taking on a fragrance industry that hasn’t changed in almost half a century
Fragrance tech company Patina says it has raised $2 million in funding investors, including Betaworks and True Ventures. …
The Physics of Brain Development: How Cells Pull Together to Form the Neural Tube
Newswise — In about one out of every 1,000 pregnancies, the neural tube, a key nervous system structure, fails…
Semaglutide Falls Short in Alzheimer’s Phase 3 Trials
Phase 3 trials show oral semaglutide failed to slow early Alzheimer’s progression, potentially limiting its expansion beyond metabolic…
GOP Sen. Johnson investigating FDA rare disease drug rejections
WASHINGTON — Sen. Ron Johnson (R-Wis.) said he is investigating the Food and Drug Administration’s rejections of rare disease…
5 Takeaways From This Week’s J.P. Morgan Healthcare Conference
The JP Morgan 2026 conference took place this week in San Francisco. getty After the dreary “biotech winter”…
Global Venture Funding In 2025 Surged As Startup Deals And Valuations Set All-Time Records
After three years of declining or flat venture investment, global startup funding grew year over year in 2025,…